The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Retrospective analysis between PD-L1 expression and prognosis for stage III non-small cell lung cancer patients who received concurrent chemoradiotherapy.

Takaaki  Tokito

No Relationships to Disclose

Koichi  Azuma

Honoraria - Chugai Pharma

Hidenobu  Ishii

Honoraria - Chugai Pharma; Pfizer; Taiho Pharmaceutical

Kazuhiko  Yamada

Honoraria - Boston Biomedical; Chugai Pharma; Pfizer; Taiho Pharmaceutical

Research Funding - Lilly Japan (Inst); Merck Sharp & Dohme (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)

Tomoaki  Hoshino

Stock and Other Ownership Interests  - Carna Biosciences

Research Funding - Chugai Pharma; GlaxoSmithKline; Novartis